Surface Engineering of Escherichia coli -Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells.

MLA

Sepahdar, Zahra, et al. “Surface Engineering of Escherichia Coli -Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells.” Frontiers in Pharmacology, vol. 12, Nov. 2021, p. 719289. EBSCOhost, https://doi.org/10.3389/fphar.2021.719289.

APA

Sepahdar, Z., Miroliaei, M., Bouzari, S., Khalaj, V., & Salimi, M. (2021). Surface Engineering of Escherichia coli -Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells. Frontiers in Pharmacology, 12, 719289. https://doi.org/10.3389/fphar.2021.719289

Chicago

Sepahdar, Zahra, Mehran Miroliaei, Saeid Bouzari, Vahid Khalaj, and Mona Salimi. 2021. “Surface Engineering of Escherichia Coli -Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells.” Frontiers in Pharmacology 12 (November): 719289. doi:10.3389/fphar.2021.719289.